Group News

Blog & Newsletter

Seeing the Liver for the Trees

The liver is an extraordinary organ; its ability to regenerate makes living liver transplants possible. But in a country where 15 percent of people who need a liver transplant will die waiting for one, living liver transplants still only make up 5-7 percent of transplants. Dr. Emond, head of transplantation and pioneer in living liver surgery, urges a culture shift.
Read More >
We interviewed Tomoaki Kato, MD, about what's new in liver treatment, and there have been big changes. Dr. Kato discusses everything from the rise in liver cancer to the cure for hepatitis C to advancements in surgery. There's a lot to be excited about and much to know.
Read More >
Liver donation is a gift of life. For irreversible liver diseases—like cirrhosis and hepatitis, but also congenital diseases present at birth—liver donation can be life-saving. While the results of liver transplantation can be miraculous and curative, equally astonishing is that successful transplantation can occur using just a portion of the donor liver.
Read More >
What's New in the Department of Surgery

NYP/Columbia Welcomes New Faculty

In 2018, we welcomed several internationally renowned physicians to the Department of Surgery at NewYork-Presbyterian/Columbia University Irving Medical Center. These men and women are leaders in their respective fields. They have a track record of innovation and their collaborative multidisciplinary team approach allows them to provide the very highest level of patient care. While these surgeons spearhead the newest treatments and techniques, they are also very compassionate communicators.
Read More >
The Department of Surgery at Columbia University Irving Medical Center (CUIMC) is very pleased to announce a gift to create the Newmyer Family Fellowship for Innovation in Surgery, with gratitude to donor Arthur G. (“Terry”) Newmyer III.
Read More >
The Center for Liver Disease and Transplantation at NYP/Columbia is making noteworthy progress in the treatment of hepatocellular cancer (HCC) and cholangiocarcinoma (CCA), cancer of the bile duct, and is the national leader in this field.
Read More >
The Center for Liver Disease and Transplantation at NYP/Columbia has created a new program to help pediatric liver transplant patients transition to adult care.
Read More >
The Center for Liver Disease and Transplantation (CLDT) in collaboration with pediatric surgery at NYP/Columbia is making noteworthy advances in the care of children with serious liver conditions, and is a national leader in this field. “Our superior outcomes are the result of unique surgical training, high patient volume, and unsurpassed multidisciplinary collaboration,” says Jean C. Emond, MD, Chief of Transplantation Services at Columbia. “The CLDT brings together leading experts hepatobiliary surgery, hepatology, gastroenterology, oncology, radiology, diagnostic testing and pathology to provide exceptional patient care.”
Read More >
Nonalcoholic fatty liver disease (NAFLD) is now the most common cause of chronic liver disease in the United States, affecting 25% of the population. Without intervention, it can lead to significant liver damage in a smaller group of those patients.
Read More >

Pages